Eslipel
Oral antihyperglycemic agent. Dipeptidyl Peptidase-4 (DPP-4) Inhibitor. Indicated for the treatment of Type-2 Diabetes Mellitus
Therapeutic Area
Type-2 Diabetes
Active Ingredient
Sitagliptin
Line
Cardiometabolism + Diabetes + Endocrinology + Medical Clinic
Presentation
25 mg x 28 tablets
50 mg x 28 tablets
100 mg x 28 tablets
